We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAGN
1826
Magnera Corp
MAGN
$460M
| $2.2M | ﹤0.01% |
9,833
-39
| -0.4% | -$8.48K |
|
1827
QuinStreet
QNST
$1.21B
| $2.2M | ﹤0.01% |
120,810
+7,530
| +7% | +$125K |
|
1828
Prothena Corp
PRTA
$450M
| $2.19M | ﹤0.01% |
44,423
+9
| +0% | +$499 |
|
1829
Virgin Galactic
SPCE
$398M
| $2.19M | ﹤0.01% |
8,193
+595
| +8% | +$215K |
|
|
HSII
1830
DELISTED
Heidrick & Struggles
HSII
| $2.19M | ﹤0.01% |
50,039
-3,119
| -6% | -$142K |
|
|
ONEM
1831
DELISTED
1Life Healthcare
ONEM
| $2.18M | ﹤0.01% |
124,021
+1,980
| +2% | +$38.4K |
|
1832
Outset Medical
OM
$90.8M
| $2.17M | ﹤0.01% |
3,143
+60
| +2% | +$44.4K |
|
|
AGNT
1833
AGNT Inc
AGNT
$734M
| $2.17M | ﹤0.01% |
64,347
-1,457
| -2% | -$60.1K |
|
|
HMHC
1834
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $2.16M | ﹤0.01% |
134,025
-2,533
| -2% | -$38.5K |
|
|
VTLE
1835
DELISTED
Vital Energy
VTLE
| $2.16M | ﹤0.01% |
35,872
+914
| +3% | +$64.5K |
|
|
EBIX
1836
DELISTED
Ebix Inc
EBIX
| $2.15M | ﹤0.01% |
70,832
+3,302
| +5% | +$105K |
|
1837
Agilysys
AGYS
$3.06B
| $2.15M | ﹤0.01% |
48,378
+1,276
| +3% | +$60.6K |
|
1838
Nabors Industries
NBR
$1.21B
| $2.15M | ﹤0.01% |
26,511
+783
| +3% | +$77.1K |
|
1839
Relay Therapeutics
RLAY
$4.33B
| $2.15M | ﹤0.01% |
70,001
+8,260
| +13% | +$261K |
|
1840
Kearny Financial
KRNY
$599M
| $2.15M | ﹤0.01% |
162,169
-4,410
| -3% | -$58K |
|
1841
Kymera Therapeutics
KYMR
$8.94B
| $2.14M | ﹤0.01% |
33,727
+474
| +1% | +$27.6K |
|
|
VCRA
1842
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.14M | ﹤0.01% |
32,968
-195
| -0.6% | -$11K |
|
|
CNR
1843
Core Natural Resources Inc
CNR
$4.45B
| $2.13M | ﹤0.01% |
93,964
-208
| -0.2% | -$5.39K |
|
1844
BGC Group
BGC
$4.89B
| $2.13M | ﹤0.01% |
457,008
-15,281
| -3% | -$76.2K |
|
1845
BridgeBio Pharma
BBIO
$16.5B
| $2.12M | ﹤0.01% |
127,332
-899
| -0.7% | -$38K |
|
|
FIRY
1846
Firy Inc
FIRY
$163M
| $2.12M | ﹤0.01% |
14,264
+584
| +4% | +$112K |
|
|
OSG
1847
Octave Specialty Group
OSG
$222M
| $2.12M | ﹤0.01% |
131,771
+2,381
| +2% | +$37.4K |
|
|
NSTG
1848
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.11M | ﹤0.01% |
50,054
-1,268
| -2% | -$55.4K |
|
1849
Stock Yards Bancorp
SYBT
$2.6B
| $2.11M | ﹤0.01% |
33,070
+735
| +2% | +$46.2K |
|
|
BRSP
1850
BrightSpire Capital
BRSP
$648M
| $2.11M | ﹤0.01% |
205,293
-4,262
| -2% | -$41.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.